Polymyalgia Rheumatica, Sjogren's Syndrome
Conditions
Brief summary
To determine the phenotype of patients having PMR symptoms and primary Sjogren syndrome (pSS), we used a French national call to identify patients combining both diseases and collected retrospective clinical and biological data.
Detailed description
A national call to identify patients combining pSS and PMR was disseminated in France. Patients with Sjögren's syndrome associated with rheumatoid arthritis were excluded. We described the global population having both diseases and compared them to two historic prospective cohorts of isolated pSS (the prospective cohort of primary Sjögren DiapSS), or isolated PMR (TENOR, a cohort of recent PMR), regarding clinical, imaging and treatments characteristics.
Interventions
None listed
Sponsors
University Hospital, Brest
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* fulfilling the ACR/EULAR 2012 criteria for PMR and the ACR/EULAR 2016 criteria for pSS
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| clinical data | at diagnosis | pain (pain scale) |
| biological data | at diagnosis | biology (CRP in mg/L) |
| histological data | at diagnosis | accesories salivary glands biopsies (focus score) |
| imaging data | at diagnosis | US (presence of shoulder involvement yes/no; hip involvement yes/no) |
| treatments data | at inclusion ( day 0) | use of methotrexate yes/no; abatacept yes/no, rituximab yes/no, corticosteroids yes/no; pilocarpine yes/no; hydroxychloroquine yes/no |
Countries
France
Contacts
Primary ContactValerie Devauchelle-Pensec
Outcome results
None listed